SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-20-012740
Filing Date
2020-06-09
Accepted
2020-06-09 16:38:12
Documents
1
Period of Report
2020-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 4200
  Complete submission text file 0001437749-20-012740.txt   5887
Mailing Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080
Business Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 385 OYSTER POINT BLVD., SUITE 9A SOUTH SAN FRANCISCO CA 94080
Business Address
Latour Wouter (Reporting) CIK: 0001652203 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35285 | Film No.: 20952362